Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brainquiry was a neurotechnology and medical device company associated with the Brainclinics ecosystem that developed wireless EEG and related physiological monitoring hardware for neurofeedback, psychophysiology, and applied neuroscience use. The company is best known for its PET EEG product family and is described by Brainclinics as having introduced the first Bluetooth-based EEG system and an early smartwatch. Its devices were used in clinical and research settings, including neurofeedback studies in ADHD and other neuropsychiatric applications. Available evidence suggests Brainquiry operated primarily as a medtech hardware company rather than a drug developer, with no conventional therapeutic pipeline. Public web presence appears limited or inactive, and the company seems to have become dormant or been functionally absorbed within the broader Brainclinics/related applied neuroscience ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brainquiry.